Manousou, P;
Cholongitas, E;
Samonakis, D;
Tsochatzis, E;
Corbani, A;
Dhillon, AP;
Davidson, J;
... Burroughs, AK; + view all
(2013)
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Gut
, 63
1005- 1013.
10.1136/gutjnl-2013-305606.
Preview |
PDF
Gut-2014-Manousou-1005-13.pdf Download (1MB) |
Abstract
Early results of a randomised trial showed reduced fibrosis due to recurrent HCV hepatitis with tacrolimus triple therapy (TT) versus monotherapy (MT) following transplantation for HCV cirrhosis. We evaluated the clinical outcomes after a median 8 years of follow-up, including differences in fibrosis assessed by collagen proportionate area (CPA).
Archive Staff Only
View Item |